Dr. Reddy’s Secures Exclusive Rights to Commercialize HLX15 in U.S. & Europe
HLX15 is a recombinant anti-CD38 fully human monoclonal antibody injection, with intravenous as well as subcutaneous formulations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
99 per cent of life sciences leaders see AI boosting revenue management in 2025: Report
Model N’s 2025 State of Revenue Report reveals shifts toward use of generative AI and automation to bolster pharmaceutical,…
Laboratory bench to life: Connecting biotechnology and sustainability impact
Praanjal Agarwal, Associate Director - Technical & Innovation at Sustain Labs Paris, highlights how the gap between innovation…
Anupriya Patel delivers keynote address at 15th IMWP
Reaffirms India’s commitment to global pharmaceutical standardisation and regulatory convergence
Indegene launches new entity in Spain
The company is strengthening its already existing employee base in Spain, with capabilities in medical affairs, data and…
Decoding the M&A landscape
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…
Trumping the Budget blues?
Perhaps the uncertainty of the Union Budget pales before the changes that US President Trump will make as he gets down to business…
Pharmexcil appoints Bhavin Mehta as Vice-Chairman
Bhavin Mehta, Wholetime Director of Kilitch Drugs (India), to focus on pharma exports and MSME growth in India’s pharma sector
ISCR hosts 18th Annual Conference, launches AI and ML paper on clinical research
The conference focused on innovation, technology, and patient-centricity in clinical research, marking ISCR’s 20-year journey
Eli Lilly appoints Winselow Tucker as President and General Manager for India
Winselow Tucker to lead Lilly India operations under the 'One India' strategic framework as Vineet Gupta transitions to a…
Dr Archana Hingorani completes tenure as Independent Director at Alembic Pharmaceuticals
Dr Archana Hingorani ceases to be a Director at Alembic Pharmaceuticals following the completion of her second consecutive…
Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer
Aalok Shanghvi to oversee global operations, R&D, and business development at Sun Pharma
Akums launches Dapagliflozin + Pioglitazone tablets for type 2 diabetes
New dual-action therapy targets insulin resistance and glycaemic control
Union Budget 2025: Pharma industry applauds key provisions on drug accessibility, R&D boost
Budget provisions focus on customs duty exemptions, R&D funding, and healthcare infrastructure expansion
Lupin receives tentative FDA approval for generic Darunavir combination tablets
It will be manufactured at Lupin’s Nagpur facility in India
Sanjaya Mariwala highlights key takeaways from Union Budget 2025
Mariwala, shares his insights on the Union Budget 2025, highlighting its impact on economic growth, MSMEs, healthcare, and skill…
Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension
Lupin announces completion of U.S. FDA Pre-Approval Inspection at its Somerset, New Jersey facility with zero 483 observations
Mixed reactions from pharma to Union Budget 2025
Appreciate extending full exemption and concessional tariffs to bulk drugs used for selected lifesaving drugs but hope for…
Exemptions, concessional duty on essential medicines to improve drug access: Sudarshan Jain, IPA
Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA) opines that by prioritising drug accessibility, robust…
Some gaps in Union Budget 2025, but positive policy-level clarifications: Anil Matai, OPPI
Anil Matai, Director General, OPPI observes that while some gaps remain, OPPI is committed to facilitating and partnering with the…